Skip to content

Use of Karanjadi Rasakriya Anjana in Klinnavartma (Ulcerative Blepharitis)

An open randomized control clinical trial of Karanjadi rasakriya anjana in Klinnavartma with special referance to Ulcerative Blepharitis - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085910
Enrollment
84
Registered
2025-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H010- Blepharitis

Interventions

None listed

Sponsors

Dr Ajay Omprakash Kadam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Shows symptoms of Klinnavartma. 2. Patient with age aboven 18 yrs to 60 years will be included. 3. Patient irrespective of Gender, educational, socioeconomic, marital status.

Exclusion criteria

Exclusion criteria: 1. Any other active acute infective ocular diseases. 2. Patient have allergic to Drugs. 3. Recently operated eye below 1 month. 4. Patient having systemic Disease likes DM. 5. Congenital anomalies of eye.

Design outcomes

Primary

MeasureTime frame
Karanjadi Rasakriya Anjana is effective in management of KlinnavartmaTimepoint: 7 Days

Secondary

MeasureTime frame
Dhatryanjana is effective in mamagement of KlinnavartmaTimepoint: 7 Days

Countries

India

Contacts

Public ContactDr Sujata Deepak Kate

Hon Shri Annasaheb Dange Ayurved Medical College And Research Center Ashta

drsujatakate@gmail.com9404701645

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026